Capital Counsel’s Mead Johnson Nutrition Company MJN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-28,161
Closed -$2.22M 127
2015
Q4
$2.22M Sell
28,161
-3,591
-11% -$283K 0.12% 44
2015
Q3
$2.23M Sell
31,752
-3,005
-9% -$247K 0.12% 45
2015
Q2
$3.14M Buy
34,757
+2,714
+8% +$262K 0.16% 40
2015
Q1
$3.22M Buy
32,043
+5,284
+20% +$533K 0.15% 40
2014
Q4
$2.69M Buy
26,759
+11,374
+74% +$1.13M 0.13% 43
2014
Q3
$1.48M Hold
15,385
0.08% 48
2014
Q2
$1.43M Sell
15,385
-114
-0.7% -$9.97K 0.08% 46
2014
Q1
$1.29M Sell
15,499
-10
-0.1% -$811 0.07% 47
2013
Q4
$1.3M Sell
15,509
-130
-0.8% -$10.6K 0.07% 50
2013
Q3
$1.16M Sell
15,639
-54,278
-78% -$4.07M 0.07% 50
2013
Q2
$5.54M Buy
+69,917
New +$5.61M 0.33% 31

Other funds holding MJN

Capital Counsel's MJN Position: Q1 2016 in Review

Capital Counsel sold out of Mead Johnson Nutrition Company (MJN) in Q1 2016, closing a stake of 28,161 shares — an estimated $2.22M sold.

Capital Counsel first reported a position in MJN in Q2 2013 and held it in 11 quarters. The position peaked at $5.54M in Q2 2013. 562 funds tracked by Wall St. Rank hold MJN as of Q1 2016.

  • Capital Counsel reported no remaining Mead Johnson Nutrition Company position as of Q1 2016 after selling out during the quarter.
  • Capital Counsel sold 28,161 Mead Johnson Nutrition Company shares in Q1 2016, an estimated $2.22M.
  • Capital Counsel first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 11 quarters.
  • Capital Counsel's Mead Johnson Nutrition Company position peaked at $5.54M in Q2 2013.
  • 562 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q1 2016.

Based on Capital Counsel's 13F filing for Q1 2016, filed 13 May 2016.